August 19, 2024 / 09:30 IST
Reported Standalone quarterly numbers for OXYGENTA PHARMACEUTICAL are:Net Sales at Rs 12.62 crore in June 2024 up 83.87% from Rs. 6.86 crore in June 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 1.36 crore in June 2024 up 70.1% from Rs. 4.56 crore in June 2023.
EBITDA stands negative at Rs. 1.76 crore in June 2024 up 51.65% from Rs. 3.64 crore in June 2023.
OXYGENTA PHARMA shares closed at 36.28 on August 16, 2024 (BSE) and has given 11.39% returns over the last 6 months and 0.69% over the last 12 months.
| OXYGENTA PHARMACEUTICAL | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 12.62 | 10.55 | 6.86 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 12.62 | 10.55 | 6.86 | | EXPENDITURE | | Consumption of Raw Materials | 10.66 | 9.04 | 8.09 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.66 | -2.12 | -1.07 | | Power & Fuel | -- | -- | -- | | Employees Cost | 1.48 | 5.25 | 0.18 | | Depreciation | 0.65 | 0.64 | 0.50 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 2.92 | 0.00 | 3.30 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -2.43 | -2.25 | -4.14 | | Other Income | 0.02 | 0.01 | -- | | P/L Before Int., Excpt. Items & Tax | -2.41 | -2.24 | -4.14 | | Interest | 0.41 | 0.59 | 0.29 | | P/L Before Exceptional Items & Tax | -2.82 | -2.83 | -4.43 | | Exceptional Items | -- | 0.25 | -0.13 | | P/L Before Tax | -2.82 | -2.59 | -4.56 | | Tax | -1.45 | -10.60 | -- | | P/L After Tax from Ordinary Activities | -1.36 | 8.02 | -4.56 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -1.36 | 8.02 | -4.56 | | Equity Share Capital | 35.48 | 33.48 | 33.48 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.39 | 2.55 | -1.65 | | Diluted EPS | -0.37 | 2.44 | -1.65 | | EPS After Extra Ordinary | | Basic EPS | -0.39 | 2.55 | -1.65 | | Diluted EPS | -0.37 | 2.44 | -1.65 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
